K974181

Substantially Equivalent

ACCUSIGN DOA 2, ACCUSIGN DOA, ACCUSIGN BAR/BZO, BIOSIGN DOA 2, BIOSIGN BAR/BZO, FIRST CHECK PANEL 2 BAR/BZO, STATUS DS B

Applicant: Princeton BioMeditech Corp.
Product code: JXM
Advisory panel: Clinical Toxicology
Date received: 1997-11-06
Decision date: 1997-12-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.